Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Issue: Reiterate the importance of animal models in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

P.L. 116-37, Bipartisan Budget Act of 2019
Issue: Support efforts to Increase discretionary spending caps and non-defense discretionary spending for fiscal year 2021.

H.R. 7614, Draft Senate, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, Ebola and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Oppose restrictions on fetal tissue research. Support animal research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic and for new curricular materials. Support emergency funding and exemptions from discretionary spending caps. Support extensions of the period of disbursement for multi-year grants. Support ongoing investment in public health infrastructure.
Issue: Support increased 302(b) funding allocations for Labor- HHS-Education and Commerce-Justice-Science Subcommittees.

H.R. 7667, Draft Senate, FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations Act
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Issues: Support funding for the National Science Foundation (NSF)

H.R. 7609, Draft Senate, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
H.R.7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021
Issues: Support funding for Veterans Affairs medical research, research infrastructure, information technology, and community care. Oppose restrictions on use of canines in VA medical research. Oppose VA research funding rescissions. Support exemption from discretionary spending caps.

H.R. 7612, Draft Senate, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2021
H.R.7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021
Issue: Support funding for Indian Health Service health professions, housing and medical equipment programs.

H.R. 7617, Department of Defense Appropriations Act, 2021
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021

H.R. 6395, S. 4049, William M. Thornberry National Defense Authorization Act for Fiscal Year 2021
Issue: Supporting funding for Department of Defense funding for medical personnel and infrastructure, as well as the Uniformed Services University of the Health Sciences (USUHS).

P.L. 116-159 Continuing Appropriations Act, 2021 and Other Extensions Act
Issue: Support continuation of discretionary funding programs. Support the reauthorization of the National Health Service Corps, Community Health Centers, and Teaching Health Centers mandatory appropriation funds. Support fixes for Medicare Accelerated and Advance Payment Programs. Support repeal or a delay in the implementation of the Medicaid disproportionate share hospital (DSH) cuts.

Presidents Budget, FY 2022
Issue: Support funding for core public health infrastructure, VA Research, and HRSA Workforce Programs.

Issues: Oppose presidents budget proposal to eliminate and consolidate graduate medical education (GME) funding, and proposal to reduce payments to hospital outpatient departments (HOPDs). Oppose presidents budget proposal to eliminate ACA Medicaid expansion and implement caps and/or block grants model, and to expand the Medicaid DSH cuts. Oppose presidents budget proposal to reduce scope of the 340B Drug Pricing Program.

PL 116-123, The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020
PL 116 - 127, The Families First Coronavirus Response Act
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
P.L. 116-139, H.R. 266, The Paycheck Protection Program and Health Care Enhancement Act Interim Package
H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act
S. 4322, Safely Back to School and Back to Work Act
S. 4320, Coronavirus Response Additional Supplemental Appropriations Act, 2020
H.R. 8406, The Heroes Act
S. 178 with Amendment No. 2652 HEALS Act
Issue: Support emergency funding to provide relief for federal research agencies, investments in new COVID-19 research, funding for research infrastructure workforce and data science. Support extensions of the period of disbursement for multi-year grants. Support ongoing investment in public health infrastructure. Support funding for testing, contact tracing, and partnerships between academic medical centers and public health departments. Support funding for preparedness, PPE, and regional centers. Ensure access to research samples. Support funding for provider relief fund. Support funding for CDC, ASPR, NIH, HRSA, CMS, Department of Education, and other agencies Support emergency funding for medical schools. Support liability protections for providers and higher education institutions during COVID-19. Support fixes for Medicare Accelerated and Advance Payment Programs. Support nonprofit medical school, hospital, and physician practice eligibility for Main Street Lending Program.

Issue: Support unique mission of academic medicine.

H.R. 7308, Research Investment to Spark the Economy Act
Issue: Support emergency funding to provide relief for federal research agencies and to extend administrative flexibilities.

Issue: Support continued funding support for World Health Organization activities.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Issue: Educate Congress regarding technology transfer and the importance of the Bayh-Dole Act to the US patent system.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

H.R. 4674, College Affordability Act
S. 2557, Student Aid Improvement Act
S. 4257, Student Loan Repayment and FAFSA Simplification Act
S. 4322, Safely Back to School and Back to Work Act
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans.

H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act
H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
S.3763, Pandemic Responder Service Award Act
H.R. 6395, William M. (Mac) Thornberry National Defense Authorization Act of 2021
Issue: Support loan forgiveness for health care professionals.

Issue: Support a change to the Department of Education Financial Aid Handbook redefining academic year for medical student loan disbursements. Issue: Support single accreditation system for graduate medical education
Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.

H.R.103, Foreign Medical School Accountability Fairness Act of 2019 Issue: Support transparency for all international medical schools.

H.R. 3418, Protecting Our Students by Terminating Graduate Rates that Add to Debt Act
Issue: Support the reinstatement of federal direct Stafford loans to graduate and professional students

Issue: Urge Department of Education to delay Sec. 117 and Title IX regulatory changes due to COVID-19

Issue: Support the consideration of race in holistic admissions. Oppose policies that prevent recognition of systemic racism on campus and curtail reforms to advance diversity.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Medicare Payment Advisory Commission (MedPAC), Education - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.

H.R. 6650, S. 3634, Health Heroes 2020 Act
S. 4055, Strengthening Americas Health Care Readiness Act
Issue: Support increased funding for the National Health Service Corps, and National Disaster Medical Service (NDMS) demonstration pilot.

Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine.

P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.

Issue: Oppose burdensome regulation of Laboratory Developed Tests

Issues: Support high-quality affordable health insurance. Support programs and funds for safety-net providers.

Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including instituting a moratorium, increasing reporting requirements on covered entities, and imposing user fees

S. 1895, Lower Health Care Costs Act
H.R. 3630, No Surprises Act
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
H.R. 3502, Protecting People From Surprise Medical Bills Act
Issues: Educate Congress on surprise medical bills and price disclosure. Support general principles for surprise medical bills draft legislation. Oppose statutory benchmark rate setting. Oppose Senate hospital/insurer contracting provisions and onerous reporting burden.

S. 1895, Lower Health Care Costs Act, Title IV
Issues: Prescription drug pricing, public health, maternal mortality, and health information technology.

Issue: Support legislation providing stable and predictable funding for quality measurement activities carried out by the National Quality Forum

Issue: Development of Enhanced Primary Care Pilot Act proposal
Issue: Educate Congress about medical education on nutrition, consent, implicit bias, and maternal health.

Issue: Oppose restrictions on diversity training for federal grantees and employees.

Issue: Educate Congress on the structural racism and inherent biases that have created health inequities that impact minority communities and other marginalized groups, including the disproportionate impact of COVID-19 on communities of color.

Issue: Support public health guidance for law enforcement regarding tactics to reduce the risk of coronavirus transmission, and to protect all personal and health data collected as part
of the COVID-19 response.

Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity.

H.R. 6637, Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.

H.R. 4004, S. 2986 Social Determinants Accelerator Act of 2019
Issue: Support grants to address social determinants of health

Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health.

S. 3750/H.R. 6837, Medicare Accelerated and Advance Payment Improvement Act of 2020
Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs.

Draft, firearm safety legislation
Issue: Support universal background checks, violence prevention programs, extreme risks protection orders, child access safety laws, and reinstating assault weapons ban.

H.R. 8, Bipartisan Background Checks Act of 2019
Issue: Support universal background checks

Issue: Support aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment, and healthcare operations.

S. 4349/H.R. 8094, Dr. Lorna Breen Health Care Provider Protection Act
Issue: Support grants directed at improving physician burnout and well-being.

P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020
P.L. 116-127, Families First Coronavirus Response Act
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES) Act H.R.6379, Take Responsibility for Workers and Families Act
H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act
S. 178 with Amendment No. 2652 HEALS Act
S. 4322, Safely Back to School and Back to Work Act
S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act
H.R. 8406, The Heroes Act
Issues: Support emergency supplemental funding and policies for federal agencies to support coronavirus preparedness, response, relief, and testing. Ensure access to research samples. Support funding for and provide recommendations for disbursement of provider relief fund. Support revised Medicare and Medicaid reimbursement policies and increased provider flexibility. Support improvements to the Medicare Accelerated and Advance Payment Programs. Support inclusion of Medicare-supported graduate medical education positions. Support an increase in the Federal Medicaid Assistance Program. Support for current telehealth waivers to be made permanent. Provide recommendations on personal protective equipment, testing, social distancing, clinical care, and other COVID related preparedness and response efforts of the federal government. Avoid imposing standards that would encourage depletion of scarce PPE and other resources. Support enhanced national COVID-19 data collection to better address health disparities. See other additions under BUD.

Issue: Support extension of public health emergency declaration.

Issue: Provide feedback on COVID-19 and pandemic response centers of excellence legislation.

Issue: Urge establishment and implementation of robust national COVID-19 testing strategy and functional and transparent supply chain. Urge CDC to update testing guidelines.

Issue: Describe medical education approach on womens health and support efforts to promote trauma-informed care.

Issue: Support science and data driven approach to HHS decision making.

Issue: Support CDC mission

S 4248, HR 7618, COVID-19 Bias and Anti-Racism Training Act
Issue: Support grant for anti-racism training in health professions programs.

H.R. 8017, Mobile Options for Testing In Our Neighborhoods (MOTION) Act
Issue: Support grants for mobile COVID-testing units.

S. 4160, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Issue: Support protections for hospitals that participate in the 340B Drug Pricing Program to temporarily allow them to remain eligible for the program.

H.R. 8283 S. 4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout a national emergency.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), White House Office, Federal Emergency Management Agency (FEMA), Office of the Vice President of the United States

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 6, The American Dream and Promise Act of 2019
S. 874, The Dream Act of 2019
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement. Support Dreamer eligibility for federal student loans.

S. 948, H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration Issue: Support policies to ensure timely and predictable processing for immigration of academic medicine community
Issue: Support extending duration of stay for physicians on visas during the COVID pandemic, expediting change of status and visa renewals, and expedite visa approvals for medical residents entering the country.

Issue: Oppose policies limiting entry of medical students, residents, researchers, and health professionals to the U.S. on the F-1, J-1, and H-1B visas.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), White House Office, Executive Office of the President (EOP), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.

H.R. 6417, Protecting Cures Act of 2020
Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria.

S. 3161, National Biomedical Research Act
Issue: Support legislation to establish a Biomedical Innovation Fund.

H.Res. 1125, Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
Issue: Support clinical trials diversity.

Issue: Support ethical use of fetal tissue in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issue: Support repeal or a delay in the implementation of the Medicaid disproportionate share hospital (DSH) cuts

Issue: Educate Congress on concerns related to potentially burdensome Medicaid supplemental payment reporting proposals

Issue: Educate Congress on the negative impact of the proposed Medicaid Fiscal Accountability Regulation (MFAR) and urge the administration to withdraw or delay the proposal

Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.

S. 1343, Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services (MOMMIES) Act Issue: Support expansion of Medicaid and CHIP coverage for postpartum women from current 90 days to 1 year.

H.R. 4996, Helping Medicaid Offer Maternity Services (MOMS) Act of 2020
Issue: Support expansion of Medicaid coverage for postpartum women.

S. 585, States Achieve Medicaid Expansion (SAME) Act of 2019
Issue: Support legislation to allow states that expanded Medicaid after 2014 to receive the same full federal matching funds as states that previously expanded Medicaid under the Affordable Care Act

H.R. 1763, S. 348, Resident Physician Shortage Reduction Act of 2019 Issue: Support additional Medicare funding for graduate medical education

H.R. 3414, H.R. 2439, Opioid Workforce Act
Issue: Support additional Medicare funding for graduate medical education for addiction medicine, addiction psychiatry, and pain medicine residency programs

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments

Issue: Oppose reduction of Medicare GME/IME payments

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.

S. 289, Rural Physician Workforce Production Act of 2019
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals

H.R.1358, Advancing Medical Resident Training in Community Hospitals Act of 2019
H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act
Issue: Support Medicare Graduate Medical Education (GME) per resident amount and cap-setting technical corrections and administrative relief.

Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose Medicare hospital cuts

Issue: Oppose overly burdensome Medicaid GME transparency language.

Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.

H.R. 5432, Medical Education for a Diverse America Act
Issue: Ensure that time medical residents spend in unconscious bias training is counted toward the determination of FTE for Medicare GME

Issue: Educate Congress on role of academic medicine as it relates to price disclosure initiatives

H.R. 3107, Improving Seniors Timely Access to Care Act of 2019
Issue: Support protecting patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency

Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs

HHS Rebate Rule
Medicare Part D benefit re-design
Issue: Support policies to reduce prescription drug prices

Issue: Support implementation of the 21st Century Cures Act (Cures) interoperability and health data sharing provisions.

Issue: Support changes and improvements to the Medicare Shared Savings Program.

Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

Issue: Support nominees for MedPAC

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

Issue: Support efforts to promote research integrity, address potential for foreign influence in science, and address harassment in science.

Issue: Support the use of a competitive peer review process for federal research grants and programs

H.R. 3038, Securing American Science and Technology Act
S. 2133, Secure American Research Act of 2019
H.R. 2500, National Defense Authorization Act for Fiscal Year 2020
Issue: Support efforts to address foreign influence on science, including stakeholder engagement from institutions of higher education.

S. 3997, Safeguarding American Innovation Act

Issue: Support JCORE efforts to address foreign influence on science and ensure a balanced approach.

Issue: Explore opportunities to improve research with cannabinoids.

Issue: Urge extension of COVID-19 related administrative flexibilities

HR 7308, S 4286, Research Investment to Spark the Economy Act
Issue: Support research relief at federal science agencies due to COVID pandemic.

Issue: Support house science committee chair request for NASEM study on impact of racism in academia.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships. Educate Congress on the national physician workforce shortages impact on VA

Issue: Support maintaining VA medical services in conjunction with VA community care.

Issue: Support continuation of local flexibility and consideration of VAs statutory education and research missions in VA medical center referral determinations and procedures. Support flexibility in the contracting process.

Issue: Support increased investments in IT and research infrastructure for the VA research program; Support Paperwork Reduction Act exemption for VA researchers.

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issue: Educate Congress on the community benefit of not-for-profit hospitals and the importance of preserving their tax-exempt status.

Issue: Support the suspension of the tax on endowments at higher education institutions.

Issue: Requesting 6-month delay for hospitals in filing IRS tax forms due to COVID-19

Issue: Support suspension of taxability of student scholarship and grant aid

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Internal Revenue Service (IRS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

H.R. 3, Lower Drug Costs Now Act of 2019
Issue: Support policies to reduce prescription drug prices

H.R. 6080, Preventing Drug Shortages Act
S. 2723, Mitigating Emergency Drug Shortages Act
Issue: Support legislation to reduce drug shortages

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes